Advisor Favors Tech Over Health Care Stocks
Raymond James Chief Investment Officer Larry Adam argues for shifting investment from health care to technology amid valuation gaps.
Updated on Nov. 7, 2026 in Stock Picks
Live Poll
Would you change your own investments based on advice to shift from health care to tech?
Raymond James Chief Investment Officer Larry Adam favors shifting investment from health care to technology. He notes health care valuations are at their highest level in 20 years while some technology companies have seen upward earnings revisions.
Why it matters
Valuation differences between sectors can shape how investors allocate portfolios across the broader U.S. market. The guidance reflects a view that some AI and semiconductor stocks are priced at a discount relative to health care.
Health care valuations are at their highest level in 20 years, according to the stated view, while some technology companies have seen upward revisions to earnings projections. The extraction does not quantify the size of the valuation gap or the revised estimates.
The players
Raymond James
Raymond James is a U.S. financial services firm that provides wealth management, investment banking, and asset management services.
Larry Adam
Larry Adam is the Chief Investment Officer at Raymond James and is known for his market commentary on asset allocation and sector trends.
The details
Adam's favored areas include mega-cap technology companies, semiconductor infrastructure, cybersecurity stocks, and hyperscalers, with preference given to larger companies for financing advantages and lower sensitivity to interest rates. Infrastructure development in artificial intelligence is ongoing.
Timeline
November 7, 2026: Date of the core event, Adam's sector preference commentary.
Market Dynamics
Adam's preference for companies with lower sensitivity to interest rates reflects how Federal Reserve policy shapes the relative appeal of large, well-financed firms. The sector rotation he describes sits within the broader macroeconomic cycle of monetary tightening and easing.
For investors weighing sector exposure, the guidance points toward reallocating holdings from health care toward mega-cap technology, semiconductor, and cybersecurity names. Portfolio decisions around interest-rate sensitivity and financing strength would be the practical considerations.
The takeaway
Sector valuation gaps can prompt reallocation, but investors should weigh how their existing holdings and risk tolerance fit a shift away from health care. Comparing valuations across sectors before acting helps ground that decision.
Further reading
Explore more guidance in the Stock Picks section for context on sector allocation choices.
Source note: This article includes information reported by TokenPost.
Live Poll
Would you change your own investments based on advice to shift from health care to tech?
